Skip to content

Drug interactions

Lonafarnib + Mitomycin

Severity: Minor

Lonafarnib and Mitomycin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a weak P-glycoprotein inhibitor and may modestly raise exposure to mitomycin. The clinical relevance is uncertain, but mitomycin has a narrow therapeutic margin.

What this interaction means in plain words

Lonafarnib and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lonafarnib belongs to Miscellaneous; Mitomycin belongs to Oncology.

Evidence level: Low

Why it happens

Weak inhibition of P-glycoprotein efflux by lonafarnib may increase mitomycin levels.

What to do

Monitor blood counts and for adverse reactions to mitomycin. Reduce the mitomycin dose if toxicity occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lonafarnib and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lonafarnib with Mitomycin?

MediHelp rates the interaction as minor. Lonafarnib and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lonafarnib is a weak P-glycoprotein inhibitor and may modestly raise exposure to mitomycin. The clinical relevance is uncertain, but mitomycin has a narrow therapeutic margin.

How serious is the interaction between Lonafarnib and Mitomycin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for adverse reactions to mitomycin. Reduce the mitomycin dose if toxicity occurs.

What other medicines interact with Mitomycin?

MediHelp also lists interactions of Mitomycin with, for example, Bacitracin, Deferiprone, Dengue vaccine. The full list is on the Mitomycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in